Second, optimization of preoperative anemia via iron or erythropoietin supplementation if appropriate and identification of risk factors for transfusion reactions and transfusion necessity are critical to reduce transfusion requirements, particularly in young, otherwise healthy patients. The gene discussed is EPO; the disease is anemia (phenotype).